Found 81 matching trials
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma PHASE2 Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Show More Location
Tangdu Hospital, Fourth Military Medical University
Learn More & Join Trial
Nab-PCE vs PC for MM After Failure of Anti-PD-1 PHASE2 This is a randomized controlled clinical trial of nab-paclitaxel + carbopla...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) PHASE3 This study is a randomized, double-Blind,international multi-Centre, phase ...
Show More Location
Multiple Locations
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP PHASE2 This trial is a single-center, prospective, single-arm Phase II clinical st...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer PHASE3 The purpose of this study is to assess the efficacy and safety of platinum-...
Show More Location
Pacific Cancer Medical Center
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I) PHASE3 A prospective, randomized, open-label, multicenter Phase 3 trial designed t...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI PHASE2 The goal of this open-label randomized, multicenter, comparative phase II t...
Show More Location
Institut de Cancérologie de l'Ouest
Learn More & Join Trial